Literature DB >> 9561361

Seroprevalence of anti-Borrelia antibodies among patients with confirmed sarcoidosis in a region of Japan where Lyme borreliosis is endemic.

M Ishihara1, S Ohno, H Ono, E Isogai, K Kimura, H Isogai, K Aoki, T Ishida, K Suzuki, S Kotake, Y Hiraga.   

Abstract

BACKGROUND: Sarcoidosis is a multisystemic granulomatous disease of unknown etiology, while Lyme borreliosis is a multisystemic disorder caused by Borrelia burgdorferi. The purpose of this study is to evaluate the relationship between sarcoidosis and Lyme borreliosis in a region of Japan where Lyme borreliosis is endemic.
METHODS: We determined the seroprevalence of anti-Borrelia burgdorferi antibodies as well as antibodies three Japanese Borrelia strains by enzyme-linked immunosorbent assay and dotblot assay using purified Borrelia-specific proteins in 46 patients with confirmed sarcoidosis and 150 controls (50 disease controls and 100 healthy controls) in Hokkaido, the affected region.
RESULTS: Fifteen patients with sarcoidosis (32.6%) tested positive for Borrelia spirochete in both assays, compared with two disease controls (4.0%) and two healthy controls (2.0%). The seroprevalence of anti-Borrelia antibodies in patients with sarcoidosis was much higher in the affected region than in the region in our previous study were Lyme borreliosis is non-endemic.
CONCLUSION: In a region where Lyme borreliosis is endemic, Borrelia infection may be partially associated with sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561361     DOI: 10.1007/s004170050078

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

Review 1.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

2.  Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort.

Authors:  Peter J Mayne
Journal:  Int J Gen Med       Date:  2014-12-23

Review 3.  Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis.

Authors:  Tiago Esteves; Gloria Aparicio; Vicente Garcia-Patos
Journal:  BMC Pulm Med       Date:  2016-11-28       Impact factor: 3.317

4.  Systemic Sarcoidosis Associated with Exposure to Borrelia burgdorferi in a 21-Year-Old Man.

Authors:  Lars van Dee; Mylene Stehouwer; Thomas van Bemmel
Journal:  Eur J Case Rep Intern Med       Date:  2018-10-24

Review 5.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

Review 6.  The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?

Authors:  Raisa Kraaijvanger; Marcel Veltkamp
Journal:  Microorganisms       Date:  2022-08-15

Review 7.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.